• Produktbild: Melanoma
  • Produktbild: Melanoma

Melanoma Biologically Targeted Therapeutics

Fr. 72.90

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.08.2012

Herausgeber

Ernest C. Borden

Verlag

Humana Press

Seitenzahl

388

Maße (L/B/H)

22.9/15.2/2.3 cm

Gewicht

600 g

Auflage

Softcover reprint of the original 1st ed. 2002

Sprache

Englisch

ISBN

978-1-4684-9668-0

Beschreibung

Rezension

"Incredible detail to immunologic mechanisms is the strong point of the book. The bibliography at the end of each chapter is exhaustive, sometimes citing over 300 references.The pharmacokinetics of cytokines are meticulously discussed and diagrammed. Tables summarizing the results of clinical trials to date are peppered throughout the book. The authors are careful not to draw conclusions that do not have support from prospective randomized clinical trials. It is an excellent source to become familiar with current research and experimental protocols for advanced melanoma. Researchers and directors of melanoma clinics at tertiary care facilities will want to have this book as a resource."-Weighted Numerical Score: 100 - 5 Stars!-Doody's Health S ciences Book Review Journal

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.08.2012

Herausgeber

Ernest C. Borden

Verlag

Humana Press

Seitenzahl

388

Maße (L/B/H)

22.9/15.2/2.3 cm

Gewicht

600 g

Auflage

Softcover reprint of the original 1st ed. 2002

Sprache

Englisch

ISBN

978-1-4684-9668-0

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Melanoma
  • Produktbild: Melanoma
  • Part I. Perspective on the Clinical Disease

    Management of Primary Malignant Melanoma
    Philip L. Bailin, Jon S. Meine, and Christine Poblete-Lopez

    A Pathologist's Perspective on Prognostic Features of Malignant Melanoma
    Ralph J. Tuthill

    Clinical Prognostic Factors and Staging
    Hamed Daw and Thomas Olencki

    Part II. Biological and Targeted Therapeutics

    Principles of Antitumor Immunity and Tumor-Mediated Immunosuppression
    Peter A. Cohen, Suyu Shu, and James H. Finke

    Immunotherapy of Advanced Melanoma Directed at Specific Antigens
    Stanley P. L. Leong and Suyu Shu

    Melanoma Antigens: Vaccines and Monoclonal Antibodies
    Paul B. Chapman and Jedd D. Wolchok

    Interleukin-2
    James W. Mier and Michael B. Atkins

    Interleukin-12: Immunologic and Antitumor Effects in Human Malignant Melanoma
    Ronald M. Bukowski and Charles Tannenbaum

    Interferons: Preclinical and Clinical Studies in Melanoma
    Ernest C. Borden

    Biochemotherapy of Melanoma
    Lawrence E. Flaherty and Philip Agop Philip

    Signal Transduction Abnormalities as Therapeutic Targets
    Ruth Halaban and Maria C. von Willebrand

    Tumor Angiogenesis
    Bela Anand-Apte and Paul L. Fox

    Antiangiogenic Therapy for Melanoma
    Vann P. Parker